DOVER, N.J., April 14 /PRNewswire/ -- Germgard Lighting LLC, a New Jersey based, early phase medical technology company, has demonstrated its patented, ultra-fast surgical instrument resterilization system. Germgard's technology will protect millions of patients and lower the overall cost of care by preventing infections resulting from surgery in large healthcare facilities, military field hospitals, and ambulatory surgical centers.
The total cycle time for the process is much shorter than for hot steam sterilization or any room-temperature, gas sterilant process. Shorter cycle times and room temperature are important since they reduce instrument damage and enhance inventory turnaround -- critical considerations for operational efficiency. The six-minute cycle time makes Germgard's method unique and ideal for all surgical venues.
According to Germgard's CEO, Dr. Eugene I. Gordon, "Deployment of our efficacious, easy-to-use, and ultra-fast sterilization products will be one of the least expensive, quickest to implement, and most effective means for healthcare facilities to immediately lower operating costs and properly protect patients undergoing surgery."
The ability to inactivate all pathogens, including spores, with room temperature techniques in just six minutes to achieve 100% kill was absolutely unimaginable only a couple of years ago. "This tabletop system, featuring scalable capacity, and available at autoclave price points, is truly disruptive," says Cheryl Perkins, President of Innovation Edge, an industry recognized Innovation thought leader.
Germgard is positioned to assist hospitals to run better, provide higher quality healthcare, produce improved patient outcomes and reduce costs. The Germgard solution for instrument resterilization will resolve the persistent issues of speed, efficacy, and instrument wear that have long plagued instrument resterilization in hospitals and clinic
|SOURCE Germgard Lighting LLC|
Copyright©2009 PR Newswire.
All rights reserved